Engineered amylase variants
The present invention provides engineered amylase polypeptides and compositions thereof. The engineered amylase polypeptides have been optimized to provide improved thermostability, protease stability, and stability under a range of pH conditions, including acidic (pH<7) conditions. The invention also relates to the use of the compositions comprising the engineered amylase polypeptides for therapeutic and/or nutritional purposes. The present invention also provides polynucleotides encoding the engineered amylase polypeptides, as well as methods for making the engineered polynucleotides and amylase polypeptides.
1. A recombinant polynucleotide comprising a polynucleotide sequence encoding a recombinant amylase comprising a polypeptide sequence comprising at least 90% sequence identity to SEQ ID NO: 1728, wherein the polypeptide sequence comprises at least a substitution 272G/K/P/R/S, 394E/G/N/R/S, or 91H, or any combinations thereof, wherein the amino acid positions are relative to SEQ ID NO: 2.
2. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least 95% sequence identity to SEQ ID NO: 1728.
3. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least 96% sequence identity to SEQ ID NO: 1728.
4. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least 97% sequence identity to SEQ ID NO: 1728.
5. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least 98% sequence identity to SEQ ID NO: 1728.
6. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least 99% sequence identity to SEQ ID NO: 1728.
7. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least the substitution 272G, 272K, 272P, 272R, or 272S.
8. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least the substitution 394E, 394G, 394N, 394R, or 394S.
9. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least the substitution 91H.
10. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises at least the substitution 272G, 394G, or 91H, or any combinations thereof.
11. The recombinant polynucleotide of claim 1 , wherein said polynucleotide sequence is codon-optimized.
12. The recombinant polynucleotide of claim 1 , wherein the polypeptide sequence of the encoded recombinant amylase comprises SEQ ID NO: 156, 174, 276, 308, 422, 456, 546, 632, 664, 780, 810, 1104, 1122, 1224, 1256, 1370, 1404, 1494, 1580, 1612, 1728, or 1758.
13. The recombinant polynucleotide of claim 1 , wherein the polynucleotide sequence comprises SEQ ID NO: 155, 173, 275, 309, 421, 455, 545, 631, 663, 779, 809, 1103, 1121, 1223, 1255, 1369, 1403, 1493, 1579, 1611, 1727, or 1757.
14. An expression vector comprising a recombinant polynucleotide of claim 1 .
15. The expression vector of claim 14 , wherein the recombinant polynucleotide is operably linked to a control sequence.
16. The expression vector of claim 15 , wherein the control sequence comprises a promoter.
17. A host cell comprising an expression vector of claim 14 .
18. The host cell of claim 17 , wherein said host cell is a bacterial cell, fungal cell, insect cell of mammalian cell.
19. A method of producing a recombinant amylase, comprising culturing a host cell of claim 17 under conditions such that the recombinant amylase encoded by the recombinant polynucleotide is produced.
20. The method of claim 19 , further comprising recovering the recombinant amylase.
21. The method of claim 19 , further comprising purifying the recombinant amylase.